Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene.

CONTEXT Paraganglioma syndrome includes inherited head and neck paragangliomas (HNPs) and adrenal or extra-adrenal pheochromocytomas and are classified according to the susceptibility genes SDHB, SDHC, and SDHD. In contrast with those with germline mutations of the SDHB and SDHD genes, clinical and genetic data on patients with mutations of SDHC are scarce. OBJECTIVE To determine the prevalence and clinical characteristics of SDHC mutation carriers compared with patients with SDHB and SDHD mutations and with sporadic cases. DESIGN, SETTING, AND PATIENTS Genetic screening for SDHC mutations in an international HNP registry of 121 unrelated index cases and in 371 sporadic cases from a pheochromocytoma registry, conducted January 1, 2001, until December 31, 2004. Identified index cases and affected relatives were clinically evaluated. MAIN OUTCOME MEASURES Prevalence of and clinical findings for SDHC mutation-associated HNPs vs those with SDHB and SDHD mutations. RESULTS The prevalence of SDHC carriers was 4% in HNP but 0% in pheochromocytoma index cases. None of the SDHC mutation carriers had signs of pheochromocytoma. We compared HNPs in 22 SDHC mutation carriers with the HNPs of SDHB (n = 15) and SDHD (n = 42) mutation carriers and with 90 patients with sporadic HNPs. Location, number of tumors, malignancy, and age were different: more carotid body tumors were found in SDHC (13/22 [59%]) than in sporadic HNPs (29/90 [32%], P = .03), as well as fewer instances of multiple tumors in SDHC (2/22) than in SDHD (24/42; P<.001), 0 malignant tumors in SDHC vs 6/15 in SDHB (P = .002), and younger age at diagnosis in SDHC than in sporadic HNPs (45 vs 52 years; P = .03). CONCLUSIONS Patients with HNP, but not those with pheochromocytoma, harbor SDHC mutations in addition to those in SDHB and SDHD. In total, more than one quarter of HNP patients carry a mutation in 1 of these 3 genes. Head and neck paragangliomas associated with SDHC mutations are virtually exclusively benign and seldom multifocal. Analysis for germline mutations of SDHC is recommended in apparently sporadic HNP to identify risk of inheritance.

[1]  C. Giaquinto,et al.  Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection. , 2006, AIDS.

[2]  Y. Maldonado,et al.  Temporal trends in early clinical manifestations of perinatal HIV infection in a population-based cohort. , 2005, JAMA.

[3]  C. Rouzioux,et al.  Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  L. Feng,et al.  SDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas , 2004, Clinical genetics.

[5]  J. Schipper,et al.  Germline Mutations in Non-syndromic Pheochromocytoma , 2004 .

[6]  R. Ferrell,et al.  An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma , 2004, Journal of Medical Genetics.

[7]  C. Eng,et al.  Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. , 2004, JAMA.

[8]  P. Schofield,et al.  The prevalence of SDHB, SDHC, and SDHD mutations in patients with head and neck paraganglioma and association of mutations with clinical features , 2004, Journal of Medical Genetics.

[9]  E. Rosenberg,et al.  Primary HIV type 1 infection. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  H. Neumann,et al.  Mutations of the SDHB and SDHD genes , 2004, Familial Cancer.

[11]  E. Leteurtre,et al.  Hereditary phaeochromocytomas and paragangliomas: a study of five susceptibility genes , 2003, Journal of medical genetics.

[12]  Charis Eng,et al.  A role for mitochondrial enzymes in inherited neoplasia and beyond , 2003, Nature Reviews Cancer.

[13]  J. Schipper,et al.  Germ-line mutations in nonsyndromic pheochromocytoma. , 2002, The New England journal of medicine.

[14]  W. Rubinstein,et al.  Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas , 2002, Journal of medical genetics.

[15]  E S Husebye,et al.  Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. , 2001, American journal of human genetics.

[16]  D. Evans,et al.  Germline SDHD mutation in familial phaeochromocytoma , 2001, The Lancet.

[17]  C. Eng,et al.  Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. , 2000, Cancer research.

[18]  Ulrich Müller,et al.  Mutations in SDHC cause autosomal dominant paraganglioma, type 3 , 2000, Nature Genetics.

[19]  D. Turnbull,et al.  Late‐onset optic atrophy, ataxia, and myopathy associated with a mutation of a complex II gene , 2000, Annals of neurology.

[20]  L. Magder,et al.  Timing of perinatal human immunodeficiency virus type 1 infection and rate of neurodevelopment. The Women and Infant Transmission Study Group. , 2000, The Pediatric infectious disease journal.

[21]  P. Pezzotti,et al.  Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry. , 2000, JAMA.

[22]  B. Devlin,et al.  Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.

[23]  U. Müller,et al.  PGL3, a third, not maternally imprinted locus in autosomal dominant paraganglioma , 1999, Neurogenetics.

[24]  P. Rothberg,et al.  Functioning carotid paraganglioma in the von Hippel-Lindau syndrome. , 1998, American journal of medical genetics.

[25]  J. D. van der Walt,et al.  Carotid body paraganglioma in von Hippel‐Lindau disease: a rare association , 1996, Histopathology.

[26]  C R Mehta,et al.  The exact analysis of contingency tables in medical research , 1994, Statistical methods in medical research.

[27]  D. Kennedy,et al.  Glomus Tumor and Multiple Endocrine Neoplasia , 1986 .

[28]  M. T. Hull,et al.  Metastatic carotid body paraganglioma in von Hippel-Lindau disease. An electron microscopic study. , 1982, Archives of pathology & laboratory medicine.

[29]  A. Kroll,et al.  HEREDITARY DEFICIENCIES OF CLOTTING FACTORS VII AND X ASSOCIATED WITH CAROTID-BODY TUMORS. , 1964, The New England journal of medicine.